- Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechsWhen Axiom's stem cell therapy demonstrated a 0% mortality rate over two years in potentially fatal newborn neurological diseases this week, the biotech's leadership saw a broader validation for th…Fierce Biotech · 9d ago↗ source
- BIO San Diego 2026 Executive InterviewsEvery year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ecosystem.Fierce Biotech · 10d ago↗ source
- Building a workforce engine for biomanufacturingOhio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.Fierce Biotech · 11d ago↗ source